24.12.2012 Views

Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

Karen Lynn Chandler Johnson, MD, MPH WORK - Office of ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Systolic Blood Pressure Intervention Trial (SPRINT). Co-Chair <strong>of</strong> the National Steering<br />

Committee and Principal Investigator. <strong>Karen</strong> C. <strong>Johnson</strong>, <strong>MD</strong>, <strong>MPH</strong>. Funded by the National<br />

Heart Lung and Blood Institute, NIH. UT has subcontract with Wake Forest and UAB for the<br />

SPRINT study. 2010 – 2015.<br />

A Clinical Trial <strong>of</strong> Two Medications on Smoking Cessation (STAR). Principal Investigator: <strong>Karen</strong><br />

C. <strong>Johnson</strong>, <strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a randomized clinical trial to assess whether a<br />

combination <strong>of</strong> the nicotine patch and sustained-release bupropion as compared to the nicotine<br />

patch or sustained-released bupropion alone will result in increased initial and longterm smoking<br />

cessation in younger low income and minority persons who smoke. Funded by the National<br />

Heart Lung and Blood Institute, NIH (RO1 HL66025-01A1). $2,721,618. 2002 - 2008.<br />

The Use <strong>of</strong> Sibutramine in Smoking Cessation (SUCCESS). Principal Investigator: <strong>Karen</strong> C.<br />

<strong>Johnson</strong>, <strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a randomized clinical trial to assess whether<br />

sibutramine compared to a placebo can prevent postcessation weight gain and help smokers<br />

stop smoking. Funded by the National Heart Lung and Blood Institute, NIH (RO1HL68049-01).<br />

$2,463,873. 2001 - 2007.<br />

Treating Nicotine Addiction in Pregnancy (RENEW). Principal Investigator: <strong>Karen</strong> C. <strong>Johnson</strong>,<br />

<strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a clinical trial looking at the efficacy <strong>of</strong> the Nicotine patch in<br />

pregnant women smokers. RO1 Grant funded by the National Institute <strong>of</strong> Drug Abuse, NIH.<br />

$349,896. 1997 - 2001.<br />

Bone Mineral Density in CHARM Participants. Principal Investigator: <strong>Karen</strong> C. <strong>Johnson</strong>, <strong>MD</strong>,<br />

<strong>MPH</strong>. Experience gained in assessing the effects <strong>of</strong> hormonal contraceptives on bone mineral<br />

density by DEXA scan in premenopausal women. Grant funded by the <strong>Office</strong> <strong>of</strong> Research on<br />

Women's Health, NIH. $99,980. 1995 - 1999.<br />

Effect <strong>of</strong> Norplant on Cardiovascular Risk in Young Women (CHARM). Principal Investigator:<br />

<strong>Karen</strong> C. <strong>Johnson</strong>, <strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a clinical trial looking at hormonal<br />

contraceptives and cardiovascular risk in premenopausal women. RO1 Grant funded by the<br />

National Institute <strong>of</strong> Child Health and Human Development, NIH. $1,151,759. 1994 - 1999.<br />

Women's Health Initiative Memory Study (WHIMS). Principal Investigator: <strong>Karen</strong> C. <strong>Johnson</strong>,<br />

<strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a multi-center randomized clinical trial examining the effect <strong>of</strong><br />

postmenopausal hormone replacement therapy on the development <strong>of</strong> dementia in women age<br />

65 years and older in the Women's Health Initiative study. Ancillary to an NIH funded grant.<br />

$247,477. 1996 - 2007.<br />

Women’s Health Initiative Sight Exam Study (WHISE). Principal Investigator: <strong>Karen</strong> C. <strong>Johnson</strong>,<br />

<strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a multi-center randomized clinical trial examining the effect <strong>of</strong><br />

postmenopausal hormone replacement therapy on the development acute macular degeneration.<br />

Ancillary to an NIH funded grant. $340,000. 2000 - 2005.<br />

Benign Breast Disease in the Women’s Health Initiative. Principal Investigator: <strong>Karen</strong> C.<br />

<strong>Johnson</strong>, <strong>MD</strong>, <strong>MPH</strong>. Experienced gained in a multi-center randomized clinical trial examining the<br />

effect <strong>of</strong> postmenopausal hormone replacement therapy on the development <strong>of</strong> benign breast<br />

disease. Ancillary to an NIH funded grant. $46,384. 2002 – 2005.<br />

Women’s Health Initiative Nutritional Biomarkers Study (NBS). Principal Investigator: <strong>Karen</strong> C.<br />

<strong>Johnson</strong>, <strong>MD</strong>, <strong>MPH</strong>. Experience gained in a multi-center study examining objective (i.e., blood<br />

and urine) measures <strong>of</strong> dietary intake to use in regression calibration models <strong>of</strong> dietary intake in<br />

the Women’s Health Initiative. Ancillary to an NIH funded grant. 2006 – 2008.<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!